Biotech / Finance

AstraZeneca gets second CRL for Zs-9 after Zs Pharma plant inspection

From in-PharmaTechnologist RSS
March 21, 2017 - 1:07am
The US FDA has issued AstraZeneca with a second CRL for its hyperkalaemia candidate Zs-9 after finding problems at a manufacturing facility operated by subsidiary Zs Pharma.


Continue reading this article »